Results 281 to 290 of about 577,818 (354)

Case Report: Recognition and management of SMARCA4-deficient renal cell carcinoma. [PDF]

Front Oncol
Wang W, Yin S, Xu D, Tai S, Cheng X, Chang Y, Fu Y, Zhou J.   +7 more
europepmc   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Clinical characteristics and survival outcomes of TFE3-rearranged renal cell carcinoma: a retrospective study compared with clear cell renal cell carcinoma using propensity score matching. [PDF]

World J Urol
Han W, Peng K, Shen Q, Chen S, Ou Z, Kang T, Yu X, Zhang J, Zhang Z.   +8 more
europepmc   +1 more source

One‐Stone‐Two‐Birds Carrier‐Free Nano‐Cocktail Enables Synergistic Eradication of Cancer Cells/Stem Cells in Breast Cancer Treatment

Exploration, EarlyView.
ABSTRACT Cancer stem cells (CSCs) are widely recognized as the culprits of chemoresistance, tumor metastasis, and relapse. Moreover, most chemotherapeutic drugs not only fail to eliminate CSCs effectively, but also induce the acquisition of stemness characteristics in non‐stem cancer cells. Herein, we propose a cancer cells/CSCs double‐killing modality
Tongyao Zhao, Yao Chen, Haimeng Yuan, Shuqian Yang, Hongyuan Zhang, Yuequan Wang, Shenwu Zhang, Qin Chen, Jin Sun, Zhonggui He, Cong Luo   +10 more
wiley   +1 more source

Anastomosing hemangioma masquerading as renal cell carcinoma in a transplanted kidney: a case report. [PDF]

Clin Transplant Res
Jung HS, Lee HK, Kim SS, Kim SW, Choi SJN.   +4 more
europepmc   +1 more source

Recent Insights on Synthesis, Stability, and Complexities of Water‐in‐Oil Pickering Emulsion: From Theory to Applications

Food Frontiers, EarlyView.
It provides a conceeptual framework of the core components required for w/o PE development and various internal and external factors determining the emulsion stabilization. It also emphasizes the emerging application of w/o PE in diverse industrial use such as encapsulation and delivery, packaging, food, biomedical, etc.
Bibha Mishra A., Vidisha Tomer
wiley   +1 more source

Renal Cell Carcinoma: Prognosis in the Era of Targeted Therapy. [PDF]

Curr Oncol
Halfter K, Staehler M, Hölzel D, Crispin A, Schlesinger-Raab A.   +4 more
europepmc   +1 more source

Maintenance of Carnitine Homeostasis as a Therapeutic Strategy to Attenuate Cisplatin‐Induced Acute Kidney Injury

Food Frontiers, EarlyView.
ABSTRACT Acute kidney injury (AKI) has emerged as a significant global public health concern due to its high morbidity and mortality rates. Cisplatin, a highly effective and widely used chemotherapeutic agent, is often limited in clinical application by its nephrotoxicity, particularly AKI.
Mingkang Zhang, Yazhi Wang, Xiujuan Wang, Yan Zhou, Yanrong Ma, Xin'an Wu   +5 more
wiley   +1 more source

Clinical value and mechanism of CDKN2A in clear cell renal cell carcinoma. [PDF]

Discov Oncol
Li Y, Wang S, Lin Y, Li J, Lan X, Lv A, Chen J, Liu Z.   +7 more
europepmc   +1 more source

CT-based AI score associates with perioperative outcomes in nephron-sparing surgery for renal cell carcinoma. [PDF]

Cancer Imaging
Shengfa L, Liqing S, Shu C, Huijian C, Yuying L, Zijie L, Yinfeng X, Qianwen L, Zhuting F, Mingping M, Minxiong H.   +10 more
europepmc   +1 more source